文献速递妇科

聚焦超声消融手术治疗腹壁子宫内膜异位症的临床价值

[Clinical value of focused ultrasound ablation surgery in the treatment of abdominal wall endometriosis].
PubMed 文献 · Zhonghua Fu Chan Ke Za Zhi · 2024-01-01

回顾性分析34例腹壁子宫内膜异位症患者接受聚焦超声消融手术(FUAS)的特征与随访结果。治疗后1个月至1年疼痛评分较治疗前显著下降(P均<0.01),1年临床有效率85%。治疗中全部患者诉皮肤热烫感,均经处理好转。

要点

  • 34例腹壁子宫内膜异位症患者行FUAS后1个月至1年疼痛评分均较治疗前显著下降。
  • 随访至1年,疼痛基本及有效缓解占74%,临床有效率85%,5例复发。
  • 术后1年病灶最大径较治疗前显著缩小,不同分型间病灶缩小存在显著差异。

核心结论

  • FUAS治疗腹壁子宫内膜异位症是有效、安全的,初步验证了其临床应用价值。

研究设计与样本

  • 回顾性分析2019年11月至2022年10月青岛市妇女儿童医院收治的行FUAS治疗的腹壁子宫内膜异位症患者共34例。

主要发现

  • 34例患者年龄(32.8±3.8)岁,病灶最大径中位数24 mm,治疗前中重度周期性疼痛30例(88%,30/34)。
  • 磁共振成像分型为浅表型19例(56%,19/34)、中间型8例(24%,8/34)、深部型7例(21%,7/34)。
  • 治疗后1、3、6个月及1年疼痛评分较治疗前显著下降(Z=-4.66、-5.13、-5.11、-4.91,P均<0.01)。
  • 治疗后1年疼痛基本缓解及有效缓解者占74%(25/34),临床有效率85%(29/34),复发5例。
  • 治疗后1个月病灶最大径较治疗前无明显变化(P>0.05),3个月、6个月、1年显著缩小(Z=-2.15、-2.67、-3.41,P均<0.05)。

关键数值与推荐

  • FUAS手术时间(64±18)min,辐照时间(385±108)s,治疗功率(103±11)W。
  • 治疗总能量(38 819±16 309)J,治疗区域体积(3.11±1.42)cm3,治疗强度(377.79±106.34)s/h。
  • 不同分型患者疼痛缓解无差异(P>0.05),病灶最大径缩小情况存在显著差异(P<0.01)。

临床怎么用

  • FUAS治疗中34例(100%,34/34)诉皮肤热烫感,19例(56%,19/34)出现治疗区疼痛,2例(6%,2/34)出现血尿,经相应处理后均好转或症状消失。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To explore the effectiveness and safety of focused ultrasound ablation surgery (FUAS) for abdominal wall endometriosis. Methods: From November 2019 to October 2022, a total of 34 patients with abdominal wall endometriosis who underwent FUAS were collected, and their clinical features, imaging features, intraoperative treatment and side effects after treatment were analyzed retrospectively, and the improvement of symptoms and re-intervention were followed up. Results: (1) Characteristics of clinical data: the average age of 34 patients with abdominal wall endometriosis was (32.8±3.8) years old. The largest diameter of the lesion was 48 mm, and the median lesion diameter was 24 mm. Thirty cases (88%, 30/34) had moderate to severe periodic pain in abdominal incision before FUAS. All patients were diagnosed by preoperative magnetic resonance imaging, including 19 cases (56%, 19/34) of superficial type, 8 cases (24%, 8/34) of intermediate type and 7 cases (21%, 7/34) of deep type. (2) FUAS treatment parameters: ablation was completed with average operation time of (64±18) minutes, average sonication time was (385±108) s, (103±11) W of average power, (38 819±16 309) J of average total energy, the average treatment area volume of (3.11±1.42) cm3, and (377.79±106.34) s/h of average treatment intensity. (3) Efficiency: the pain of patients after FUAS was significantly relieved, and the pain scores of patients after 1 month, 3 months, 6 months and 1 year after FUAS were significantly decreased (Z=-4.66, -5.13, -5.11 and -4.91, all P<0.01). One year after FUAS, the near relief and effective pain relief rate was 74% (25/34), and the clinical effective rate was 85% (29/34). Five patients recurred after one year, including 3 patients who underwent abdominal wall endometriosis lesion resection and 2 patients who received drug treatment. One month after FUAS, the size of the lesion did not change significantly compared with that before FUAS (P>0.05), and the size of the lesion decreased significantly after FUAS at 3 months, 6 months and 1 year (Z=-2.15, -2.67 and -3.41, all P<0.05). It has no difference in pain relief among different types (P>0.05), but has significant difference in focus reduction among three types (P<0.01). (4) Safety: there were 34 cases (100%, 34/34) of skin burning sensation, 19 cases (56%, 19/34) of pain in the treatment area and 2 cases (6%, 2/34) of hematuria. All patients got better after corresponding treatments. Conclusion: FUAS is safe and effective for the treatment of abdominal wall endometriosis, which has clinical application value. 目的: 分析聚焦超声消融手术(FUAS)治疗腹壁子宫内膜异位症(AWE)的有效性、安全性。 方法: 收集2019年11月至2022年10月青岛市妇女儿童医院收治的行FUAS治疗的AWE患者共34例,回顾性分析其临床特征、影像学特征、FUAS治疗的相关情况及治疗后不良反应,并随访其症状改善及复发再干预情况。 结果: (1)患者的临床资料特点:34例AWE患者的年龄为(32.8±3.8)岁,病灶最大径的中位数为24 mm(最小值为15 mm,最大值为48 mm);治疗前腹壁病灶周期性疼痛为中、重度者30例(88%,30/34);治疗前行磁共振成像检查显示浅表型19例(56%,19/34),中间型8例(24%,8/34),深部型7例(21%,7/34)。(2)FUAS治疗参数:手术时间为(64±18)min,辐照时间为(385±108)s,治疗功率为(103±11)W,治疗总能量为(38 819±16 309)J,治疗区域体积为(3.11±1.42)cm3,治疗强度为(377.79±106.34)s/h。(3)有效性结果:FUAS治疗后1个月、3个月、6个月、1年疼痛较治疗前明显缓解,疼痛评分较治疗前显著下降(Z=-4.66、-5.13、-5.11、-4.91,P均<0.01)。随访至FUAS治疗后1年,疼痛基本缓解及有效缓解者的占比为74%(25/34),临床治疗有效率为85%(29/34)。随访至治疗后1年,共5例患者复发,其中3例复发后行经腹AWE病灶切除术,2例予药物治疗。FUAS治疗后1个月病灶最大径较治疗前无明显变化(P>0.05),但治疗后3个月、6个月、1年病灶最大径较治疗前显著缩小(Z=-2.15、-2.67、-3.41,P均<0.05)。不同分型的AWE患者疼痛缓解情况无差异(P>0.05),病灶最大径的缩小情况存在显著差异(P均<0.01)。(4)安全性结果:FUAS治疗中34例患者均诉皮肤热烫感,19例(56%,19/34)患者出现术后治疗区疼痛,2例(6%,2/34)患者术后即刻血尿,经相应处理后均好转或症状消失。 结论: FUAS治疗AWE是有效、安全的,初步验证了其临床应用价值。.

来源:Zhonghua Fu Chan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Ding K, Kang YJ, Zhao L, et al. [Clinical value of focused ultrasound ablation surgery in the treatment of abdominal wall endometriosis]. Zhonghua Fu Chan Ke Za Zhi. 2024. PMID: 38544448. doi:10.3760/cma.j.cn112141-20231018-00157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。